Catalog No.
Product Name
Application
Product Information
Citations
-
Bacterial Mutagenic Compound
Catalpin is an iridoid compound derived from Catalpae Fructus, known for its mutagenic activity. It exhibits significant mutagenicity towards the Salmonella typhimurium strain TA100, making it a valuable reagent for studying bacterial mutation mechanisms. This compound is useful in research applications focused on mutagenesis and the assessment of genetic variations induced by environmental factors. -
Anti-Bacterial Agent
Istamycin B is an anti-bacterial agent that demonstrates potent activity against both Gram-positive and Gram-negative bacteria. Its mechanism of action involves disrupting bacterial cell wall synthesis, leading to cell lysis and death. This compound is valuable for research applications focusing on developing new antibiotics and understanding bacterial resistance mechanisms. -
Anti-Bacterial Agent
Cephamycin B is a β-lactam antibiotic that exerts its antibacterial effects by inhibiting bacterial cell wall synthesis. It demonstrates moderate activity against both Gram-positive and Gram-negative bacteria. This compound is particularly useful in microbiological research for studying antibiotic resistance and bacterial growth dynamics. -
Antibacterial Agent
K13787 is an acetohydroxyacid synthase (AHAS) inhibitor that exhibits antibacterial activity. This compound demonstrates efficacy against a range of nontuberculous mycobacteria (NTM) and strains resistant to clarithromycin. K13787 is valuable for research involving antibacterial resistance mechanisms and the development of new therapeutic agents targeting mycobacterial infections. -
Antimycobacterial Agent
Antitubercular agent-57 is a selective antimycobacterial agent targeting Mycobacterium tuberculosis. It demonstrates significant efficacy against both drug-sensitive and multidrug-resistant strains, including extensively drug-resistant variants, while maintaining low toxicity towards mammalian cell lines, such as hepatocytes. Antitubercular agent-57 exhibits no cross-resistance with established first and second-line antitubercular agents and shows no antimicrobial activity against Gram-positive and Gram-negative bacteria or fungal strains. This reagent is valuable for research focused on tuberculosis and multidrug-resistant tuberculosis. -
Anti-Bacterial Agent
Chrysospermin A is an antibacterial agent with demonstrated activity against various Gram-positive bacteria, including Staphylococcus aureus and Bacillus subtilis, as well as against Klebsiella pneumoniae. Additionally, it exhibits inhibitory effects on individual yeast species such as Ocher echinoderma and Saccharomyces cerevisiae. This compound is valuable for research applications focused on the development of antibacterial therapies and the study of antimicrobial resistance. -
Antibacterial Agent
LL-BM123γ2 is an antibacterial agent that exhibits activity against a broad spectrum of microorganisms. Its efficacy makes it suitable for research applications focused on understanding antibacterial mechanisms and developing new therapeutic strategies. -
Anti-Bacterial Agent
Cinerubin R is an anti-bacterial agent that exhibits potent activity against Gram-positive bacteria. Additionally, it demonstrates inhibitory effects on tumor cell proliferation and is effective against multidrug-resistant (MDR) cells, displaying similar inhibitory potency to protocells. This compound is valuable for research in antibacterial therapies and cancer treatment strategies. -
Anti-Bacterial Agent
Basidalin is an anti-bacterial agent exhibiting activity against both Gram-positive and Gram-negative bacteria. It has demonstrated efficacy in inhibiting the proliferation of mouse leukemia L-1210 cells, making it a valuable tool for research in microbiology and oncology. Its broad-spectrum antibacterial properties and potential antitumor activity support various applications in experimental studies related to infectious diseases and cancer research. -
Anti-Bacterial Agent
Ochracenomicin C is an antibacterial agent derived from the strain Amicolatopsis sp. MJ 950-891. It exhibits moderate antibacterial activity, demonstrating potential utility in studying antibiotic resistance and the mechanisms of bacterial growth inhibition. This compound may serve as a valuable tool in research focused on developing new antibacterial strategies. -
Anti-Bacterial Agent
Ilicicolin B is a potent anti-bacterial agent that specifically inhibits Bacillus carbonifera at a concentration of 6 μg/mL. Its selectivity is highlighted by a toxic concentration of 0.3 μg/mL in HeLa cells. This compound is valuable for research on bacterial infections and the study of bacterial resistance mechanisms. -
Anti-Bacterial Agent
Cinnatriacetin B is a natural compound derived from the fungus Fistulina hepatica, primarily exhibiting anti-bacterial activity against Gram-positive bacteria. Its unique mechanism of action makes it a valuable agent for studying bacterial inhibition and resistance mechanisms. Cinnatriacetin B is applicable in microbiological research and offers potential insights into the development of novel antibacterial therapies. -
Anti-Bacterial Agent
Dactylocycline E is an anti-bacterial agent that exhibits activity against Gram-positive bacteria. This compound is particularly valuable in the study of bacterial infections and the development of novel antimicrobial therapies. Its mechanism of action involves inhibition of bacterial protein synthesis, making it an important tool in microbiological research. -
Anti-Bacterial Agent
Fenbenicillin potassium is a semi-synthetic penicillin that targets bacterial cell wall synthesis. It exhibits potent antibacterial activity against a range of Gram-positive and certain Gram-negative bacteria. This reagent is primarily utilized in microbiological research to study bacterial infections and antibiotic resistance mechanisms. -
Anti-Bacterial Agent
Coriolin B is an anti-bacterial agent that exhibits significant activity against Gram-positive bacteria, as well as limited efficacy against Gram-negative bacteria and yeast. At a concentration of 5 μg/mL, Coriolin B demonstrates an inhibitory effect on the growth of Yoshida sarcoma by 61.6%. Notably, it shows no inhibitory effect on Ehrlich ascites carcinoma in animal models, highlighting its selective action. This compound is useful for research applications focused on antimicrobial activity and cancer biology. -
Antibacterial Peptide
Albonoursin is an antibacterial peptide derived from microbial secondary metabolites, primarily targeting bacterial cell membranes. This compound exhibits significant antibacterial activity against a range of pathogenic organisms and shows potential for antitumor activity as well. Albonoursin is valuable in research focused on antibiotic development and cancer therapeutics. -
Anti-Bacterial Agent
Curromycin A is an antibacterial agent primarily targeting Gram-positive bacteria, including Bacillus subtilis. It exhibits notable antibacterial activity and has demonstrated the ability to inhibit the replication of human immunodeficiency virus (HIV). Additionally, Curromycin A has shown efficacy against mouse melanoma B16 and leukemia P388 cell lines, making it a useful reagent for various biological research applications. -
Anti-Bacterial Agent
Cepacin B is an anti-bacterial agent that exhibits activity against both Gram-positive and Gram-negative bacteria. This compound can be utilized in various research applications focused on bacterial inhibition and antibiotic development. Its broad-spectrum efficacy makes it a valuable tool in microbiological studies. -
Antibacterial Agent
LY 255262 is an antibacterial agent that demonstrates potent inhibitory activity against a range of Gram-positive and Gram-negative bacteria. In vitro studies reveal minimum inhibitory concentration (MIC) values of 64 μg/mL for Staphylococcus aureus, 0.25 μg/mL for Streptococcus pneumoniae, and 0.5 μg/mL for Haemophilus influenzae, among others. Notably, LY 255262 exhibits a reduced effect on Pseudomonas species with an MIC greater than 128 μg/mL. This compound is suitable for applications in antibacterial research. -
Antibacterial Agent
Antibacterial Agent 174 targets bacterial infections through its potent anti-infective properties. This compound exhibits significant efficacy in vivo, demonstrating favorable pharmacokinetic profiles. Antibacterial Agent 174 is particularly effective in biofilm removal, while exhibiting low hemolytic activity and acceptable toxicity towards mammalian cells, making it a valuable tool for research on bacterial infections and treatment strategies. -
Anti-Bacterial Agent
Oleficin is an anti-bacterial agent that demonstrates resistance to Gram-positive bacteria. This compound has shown effectiveness in preclinical models, particularly in addressing subcutaneous transplantation of Yoshida sarcoma. Its biological activity makes it a valuable tool for research in infectious diseases and tumor biology. -
Anti-Bacterial Agent
Paulomenol A is an antibacterial agent that exhibits potent activity against Gram-positive bacteria, including Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This compound is of significant interest for research applications aimed at combating bacterial infections and exploring new therapeutic strategies in antimicrobial drug development. Its effectiveness in inhibiting the growth of these pathogens makes it a valuable tool for investigating antibacterial mechanisms and resistance. -
Bacterial Metabolite
Ilicicolin F is a fungal metabolite that primarily targets bacterial oxidases, specifically inhibiting T. vivax alternative oxidase and E. coli ubiquinol oxidase cytochrome bo, with IC50 values of 0.43 and 0.37 μM, respectively. It exhibits antifungal activity against Aspergillus fumigatus and Candida albicans, demonstrating minimum inhibitory concentrations ranging from 1.66 to 13.33 μg/mL. Additionally, Ilicicolin F displays significant cytotoxicity in HeLa cells, with an EC50 value of 0.003 μg/mL, making it a potent candidate for research in microbial and cancer studies. -
Antibacterial Agent
Arizonin C3 is a microbial metabolite that exhibits antibacterial activity primarily against Gram-positive bacteria. Its mechanism of action involves disrupting cell wall synthesis, making it a valuable tool for studies focused on bacterial resistance and the development of novel antimicrobial agents. Arizonin C3 is suitable for research applications in microbiology and antibiotic development. -
Antibacterial Agent
Hypercalin B is an antibacterial agent derived from the hexane and chloroform extracts of Hypericum acmosepalum. It demonstrates significant inhibitory activity against multidrug-resistant strains of Staphylococcus aureus, with a minimum inhibitory concentration (MIC) range of 0.5-128 mg/L. This compound is relevant for research applications focused on combating resistant bacterial infections and studying natural product-derived antibacterial mechanisms. -
Anti-Bacterial Agent
Cinnatriacetin A is an anti-bacterial agent derived from the fungal strain Fistulina hepatica. It exhibits selective activity against Gram-positive bacteria, making it a valuable reagent for studies focused on bacterial inhibition and resistance mechanisms. Its unique properties make it suitable for research applications in microbiology and antibiotic development. -
Anti-Bacterial Agent
Olivomycin C is an anti-bacterial agent primarily targeting Gram-positive bacteria. It exhibits potent activity against various strains, while demonstrating limited efficacy against Gram-negative bacteria. This compound is valuable for research applications focused on developing new antibacterial strategies and studying mechanisms of bacterial resistance. -
Bacterial Inhibitor
Fenvalerate-d6 is a deuterium-labeled derivative of Fenvalerate, primarily targeting bacterial inhibition. This compound exhibits potent antibacterial activity, making it valuable for research applications focused on elucidating bacterial resistance mechanisms and evaluating the efficacy of antibacterial agents. Its isotopic labeling enables tracking and quantification in metabolic studies and pharmacokinetic investigations. -
Anti-Bacterial Agent
Parimycin is an anti-bacterial agent that exhibits activity against both Gram-positive and Gram-negative bacteria, while showing no effect on fungal species. This compound has demonstrated the ability to inhibit various tumor cell lines, including GXF 251L, H640, LXFA 629L, MCF-7, and MEXF 514L, with IC70 values ranging from 0.9 to 6.7 μg/mL. Parimycin serves as a valuable research tool for studying antibacterial mechanisms and evaluating potential therapeutic strategies against certain tumors. -
Antibacterial Agent
Antibacterial Agent 313 is a broad-spectrum antibacterial compound that targets bacterial cell growth and proliferation. It demonstrates significant efficacy against a range of bacterial strains, making it a valuable tool in the study of bacterial infections. This reagent is suitable for various research applications focused on understanding antibacterial mechanisms and developing new therapeutic strategies. -
Anti-Bacterial Agent
Fumigatin is an anti-bacterial agent that exhibits activity against Gram-positive bacteria, with weaker efficacy against Gram-negative bacteria, including Vibrio cholerae. This compound is valuable in research focusing on bacterial infections and the development of novel antibacterial therapies. Its broad-spectrum properties make it a potential candidate for studies aiming to understand bacterial resistance and the mechanism of action of antibacterial agents. -
Anti-Bacterial Agent
Manumycin G is an anti-bacterial agent that primarily targets Gram-positive bacteria, demonstrating notable efficacy against Escherichia coli. While its effectiveness against Gram-negative bacteria is limited, it shows weak cytotoxic activity in human cancer cell lines, with an IC50 of 15.6 μg/mL against HCT-116. This compound is valuable in research focused on bacterial infections and cancer biology, particularly in studies involving RAS signaling pathways. -
Bacterial
Luteoreticulin is a nitro-containing bacterial metabolite targeting various biological systems, originally isolated from Sphingobacterium luteoreticuli. It exhibits significant mosquitocidal activity against Aedes aegypti, demonstrating efficacy at a concentration of 6.25 mg/L, as well as nematocidal activity against Caenorhabditis elegans. This compound is valuable for research in pest control and nematode biology. -
Anti-Bacterial Agent
Pillaromycin A is an anti-bacterial agent that exhibits activity against mycobacteria and Gram-positive bacteria, with comparatively weaker effects on Gram-negative bacteria. Additionally, this compound demonstrates antitumor properties, making it a potential candidate for research in antimicrobial and cancer therapeutics. Its diverse biological activities highlight its utility in microbiological and oncological studies. -
Anti-Bacterial Agent
Juglomycin B is an antibacterial agent with demonstrated broad-spectrum efficacy against various bacterial and mycobacterial strains. In preclinical studies, it has shown the potential to inhibit Ehrlich ascites carcinoma in murine models and extend survival at a dosage of 1 mg/kg. This compound is valuable for research in antibacterial drug development and cancer therapeutics. -
Anti-Bacterial Agent
Nocardicyclin B is an anti-bacterial agent that exhibits resistance against Gram-positive bacteria, mycobacterium, and Nocardia species. This compound's mechanism of action involves disruption of bacterial cell wall synthesis, leading to cell lysis and death. Nocardicyclin B is valuable for research applications focused on studying bacterial resistance mechanisms and developing novel antimicrobial therapies. -
Anti-Bacterial Agent
Carpetimycin D is a potent anti-bacterial agent that exhibits strong activity against both Gram-positive and Gram-negative bacteria, including strains that produce β-lactamase. This compound effectively inhibits β-lactamase activity, making it a valuable tool for research applications aimed at understanding and combating antibiotic resistance. Its broad-spectrum efficacy makes it suitable for studying bacterial infections and developing new therapeutic strategies. -
Bacterial Inhibitor
(E/Z)-Aureusidin is a flavonoid compound that functions as a bacterial inhibitor through its antioxidant properties. It effectively inhibits the production of reactive oxygen species, thereby reducing cellular damage and inflammation by lowering the expression of inflammatory factors. Additionally, (E/Z)-Aureusidin exhibits broad-spectrum antimicrobial activity, highlighting its potential applications in combating bacterial infections and studying inflammatory responses. -
Antibacterial Agent
Tetrabutylammonium (nitrite) acts as an antibacterial agent through its ability to disrupt bacterial cellular processes. This compound demonstrates inhibitory activity against a variety of Gram-negative and Gram-positive bacteria, making it a valuable tool for research into antibacterial mechanisms and the development of new antimicrobial therapies. Its unique properties facilitate the study of bacterial resistance and sensitivity profiles in microbiological research applications. -
Anti-Bacterial Agent
Oganomycin GA is an anti-bacterial agent derived from the fermentation of Streptomyces strain oganonensis Y-G 19Z. It exhibits potent inhibitory activity against both Gram-positive and Gram-negative bacteria, attributed to its interactions with D-amino acid oxidase and its stable chemical structure. This compound is a valuable tool for research into bacterial resistance mechanisms and the development of new antimicrobial therapies. -
Anti-Bacterial Agent
Saccharocin is an antibiotic with demonstrated efficacy against both Gram-positive and Gram-negative bacteria, including strains resistant to aminoglycoside antibiotics. Its mechanism of action involves disrupting bacterial cell wall synthesis, rendering it a valuable tool in antibacterial research. This compound is applicable in studies aimed at understanding antibiotic resistance and developing new therapeutic strategies against bacterial infections. -
Antibacterial Agent
Arizonin A2 is a microbial metabolite that exhibits strong antibacterial activity, specifically targeting Gram-positive bacteria. This compound can be utilized in research focused on antibacterial agents, providing insights into microbial interactions and potential therapeutic applications against resistant strains. Its unique mechanism of action makes it a valuable candidate for studies in microbiology and drug development. -
Antibacterial Agent
BAY-Y 3118 hydrochloride is a quinolone antibacterial agent targeting bacterial infections. It demonstrates a broad antibacterial spectrum in vitro, exhibiting strong activity against gram-positive cocci and anaerobes, with moderate efficacy against Enterobacteriaceae and Pseudomonas aeruginosa. This reagent is useful for research applications in infectious diseases, providing a valuable tool for studying antibacterial mechanisms and resistance. -
Antibacterial Agent
(E)-Pinocembrin chalcone is an antibacterial compound derived from Helichrysum trilineatum. It exhibits significant antibacterial activity, making it a valuable reagent for research applications focused on bacterial infections and antimicrobial studies. This compound serves as a potential lead for the development of novel antibacterial agents. -
Anti-Bacterial Agent
Fosfadecin is an anti-bacterial agent that demonstrates moderate antibacterial activity. It is utilized in research to study bacterial infections and evaluate potential therapeutic strategies against bacterial pathogens. Its mechanism of action may provide insights into the development of new antibacterial compounds. -
Antibacterial Agent
Aspersitin is a bioactive metabolite derived from Aspergillus parasiticus, exhibiting potent antibacterial properties. This compound has demonstrated effectiveness against various bacterial strains, making it a valuable research tool in the study of antibacterial mechanisms and the development of new antimicrobial agents. Its utility extends to exploring the biochemical pathways involved in bacterial resistance and susceptibility. -
Antibacterial Agent
Fusaricidin B is an antibacterial agent derived from the lipopeptide biosurfactant of the marine bacterium Paenibacillus polymyxa. This compound exhibits significant inhibitory effects on the formation of biofilms across various bacterial species, including both Gram-positive and Gram-negative bacteria. Additionally, Fusaricidin B demonstrates the ability to disrupt complex and mature biofilms, making it a valuable tool for research into bacterial infections and biofilm-related challenges. -
Anti-Bacterial Agent
Cyathin A3 is an anti-bacterial agent with demonstrated activity against Gram-positive bacteria, Gram-negative bacteria, actinomycetes, and dermatophytes. In addition to its anti-bacterial properties, Cyathin A3 exhibits protective effects in ischemic conditions, showing potential for improving cerebral ischemia in relevant rat models. This compound is valuable for research in microbiology and neurological studies. -
Anti-Bacterial Agent
Chrysospermin D functions as an anti-bacterial agent, exhibiting potent antibacterial activity against various Gram-positive bacteria, including Staphylococcus aureus and Bacillus subtilis, as well as Klebsiella pneumoniae. Additionally, it demonstrates efficacy against specific yeasts such as Ocher echinoderma and Saccharomyces cerevisiae. This compound is useful for research applications focused on bacterial and yeast infections, as well as studies investigating antibacterial mechanisms. -
Anti-Bacterial Agent
Carpetimycin B is a potent anti-bacterial agent known for its robust activity against both Gram-positive and Gram-negative bacteria, including strains that produce β-lactamase. It effectively inhibits β-lactamase activity, making it a valuable tool for research on antibiotic resistance and bacterial infections. This compound is particularly relevant in studies aimed at understanding bacterial mechanisms and developing novel antibacterial therapies.
